Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cost of Goods | N/A | -6 | 3 | 1 | -106 |
| Gross Profit | N/A | 6 | -3 | -1 | 106 |
| Operating Expenses | 5,791 | 5,542 | 4,147 | 6,927 | 5,874 |
| Operating Income | -5,791 | -5,542 | -4,147 | -6,927 | -5,874 |
| Other Income | 732 | 822 | -132 | 129 | -80 |
| Pre-tax Income | -5,059 | -4,720 | -4,279 | -6,798 | -5,954 |
| Net Income Continuous | -5,059 | -4,720 | -4,279 | -6,798 | -5,954 |
| Net Income | $-5,059 | $-4,720 | $-4,279 | $-6,798 | $-5,954 |
| EPS Basic Total Ops | -0.18 | 4.70 | -0.23 | -2.64 | -3.05 |
| EPS Basic Continuous Ops | -0.18 | 4.45 | -0.23 | -2.64 | -2.76 |
| EPS Diluted Total Ops | -0.18 | 4.70 | -0.23 | -2.64 | -3.05 |
| EPS Diluted Continuous Ops | -0.18 | 4.45 | -0.23 | -2.64 | -2.76 |
| EPS Diluted Before Non-Recurring Items | -0.48 | N/A | -1.64 | N/A | N/A |
| EBITDA(a) | $-5,766 | $-5,516 | $-4,122 | $-6,910 | $-5,855 |